3,5-Difluoromethcathinone
A synthetic cathinone derivative
| 3,5-Difluoromethcathinone | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | Oral, Insufflation |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Uncontrolled |
| CAS Number | 1445560-00-8 |
| PubChem | 71301334 |
| DrugBank | |
| ChemSpider | 29341892 |
| KEGG | |
3,5-Difluoromethcathinone (also known as 3,5-DFMC) is a synthetic cathinone derivative. It is a member of the substituted cathinones class, which are structurally related to the naturally occurring compound cathinone found in the khat plant.
Chemical structure and properties
3,5-Difluoromethcathinone is characterized by the presence of two fluorine atoms at the 3 and 5 positions of the phenyl ring. The chemical structure of 3,5-DFMC is similar to that of other synthetic cathinones, with a ketone group at the beta position relative to the amine group. This structural similarity contributes to its pharmacological effects.
Pharmacology
As a synthetic cathinone, 3,5-DFMC is believed to act as a central nervous system stimulant. It is thought to increase the levels of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain, leading to increased alertness, euphoria, and energy. However, the exact mechanism of action and the full range of effects of 3,5-DFMC are not well understood.
Usage and effects
3,5-Difluoromethcathinone is typically used recreationally for its stimulant effects. Users may experience increased energy, enhanced mood, and heightened sensory perception. However, the use of synthetic cathinones can also lead to adverse effects such as anxiety, paranoia, and tachycardia.
Legal status
The legal status of 3,5-DFMC varies by country. In some jurisdictions, it may be classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may remain unregulated.
Safety and risks
The use of 3,5-DFMC carries significant risks, including the potential for addiction, overdose, and adverse reactions. The lack of research on its long-term effects further complicates the assessment of its safety profile.
Related pages
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian